| Year |
Citation |
Score |
| 2023 |
Lee H, Jung JH, Ko HM, Park H, Segall AM, Sheffmaker RL, Wang J, Frey WD, Pham N, Wang Y, Zhang Y, Jackson JG, Zeng SX, Lu H. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5. Proceedings of the National Academy of Sciences of the United States of America. 120: e2308292120. PMID 38032932 DOI: 10.1073/pnas.2308292120 |
0.685 |
|
| 2023 |
Chiu FY, Kvadas RM, Mheidly Z, Shahbandi A, Jackson JG. Could senescence phenotypes strike the balance to promote tumor dormancy? Cancer Metastasis Reviews. PMID 36735097 DOI: 10.1007/s10555-023-10089-z |
0.381 |
|
| 2022 |
Shahbandi A, Chiu FY, Ungerleider NA, Kvadas R, Mheidly Z, Sun MJS, Tian D, Waizman DA, Anderson AY, Machado HL, Pursell ZF, Rao SG, Jackson JG. Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. Nature Cancer. PMID 36482233 DOI: 10.1038/s43018-022-00466-y |
0.309 |
|
| 2022 |
Frey WD, Anderson AY, Lee H, Nguyen JB, Cowles EL, Lu H, Jackson JG. Phosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells. Plos Biology. 20: e3001858. PMID 36279312 DOI: 10.1371/journal.pbio.3001858 |
0.697 |
|
| 2022 |
Park VS, Sun MJS, Frey WD, Williams LG, Hodel KP, Strauss JD, Wellens SJ, Jackson JG, Pursell ZF. Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development. Nar Cancer. 4: zcac004. PMID 35252866 DOI: 10.1093/narcan/zcac004 |
0.699 |
|
| 2020 |
Shahbandi A, Rao SG, Anderson AY, Frey WD, Olayiwola JO, Ungerleider NA, Jackson JG. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer. Cell Death and Differentiation. PMID 32457483 DOI: 10.1038/s41418-020-0564-6 |
0.718 |
|
| 2020 |
Tonnessen-Murray CA, Jackson JG. Engulfment and cannibalism drive persistence of chemotherapy-treated tumor cells: can they be targeted? Molecular & Cellular Oncology. 7: 1688601. PMID 31993500 DOI: 10.1080/23723556.2019.1688601 |
0.361 |
|
| 2019 |
Tonnessen-Murray CA, Frey WD, Rao SG, Shahbandi A, Ungerleider NA, Olayiwola JO, Murray LB, Vinson BT, Chrisey DB, Lord CJ, Jackson JG. Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival. The Journal of Cell Biology. PMID 31530580 DOI: 10.1083/Jcb.201904051 |
0.723 |
|
| 2018 |
Ungerleider NA, Rao SG, Shahbandi A, Yee D, Niu T, Frey WD, Jackson JG. Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment. Breast Cancer Research : Bcr. 20: 115. PMID 30285883 DOI: 10.1186/S13058-018-1044-5 |
0.686 |
|
| 2018 |
Tonnessen-Murray C, Ungerleider NA, Rao SG, Wasylishen AR, Frey WD, Jackson JG. p53 Mediates Vast Gene Expression Changes That Contribute to Poor Chemotherapeutic Response in a Mouse Model of Breast Cancer. Translational Oncology. 11: 930-940. PMID 29852458 DOI: 10.1016/J.Tranon.2018.05.003 |
0.71 |
|
| 2016 |
Rao SG, Jackson JG. SASP: Tumor Suppressor or Promoter? Yes! Trends in Cancer. 2: 676-687. PMID 28741506 DOI: 10.1016/j.trecan.2016.10.001 |
0.348 |
|
| 2016 |
Tonnessen-Murray CA, Lozano G, Jackson JG. The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence. Cold Spring Harbor Perspectives in Medicine. PMID 27881444 DOI: 10.1101/Cshperspect.A026112 |
0.339 |
|
| 2014 |
Li Q, Zhang Y, El-Naggar AK, Xiong S, Yang P, Jackson JG, Chau G, Lozano G. Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumors. Molecular Cancer Research : McR. 12: 901-11. PMID 24598047 DOI: 10.1158/1541-7786.Mcr-14-0089 |
0.319 |
|
| 2012 |
Jackson JG, Pant V, Li Q, Chang LL, Quintás-Cardama A, Garza D, Tavana O, Yang P, Manshouri T, Li Y, El-Naggar AK, Lozano G. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell. 21: 793-806. PMID 22698404 DOI: 10.1016/J.Ccr.2012.04.027 |
0.372 |
|
| 2012 |
Lin S, Yu L, Yang J, Liu Z, Karia B, Bishop AJR, Jackson J, Lozano G, Copland JA, Mu X, Sun B, Sun L. Abstract 1069: Mutant p53 disrupts the role of ShcA in balancing the Smad-dependent and -independent signaling activity of TGF-β Cancer Research. 72: 1069-1069. DOI: 10.1158/1538-7445.Am2012-1069 |
0.348 |
|
| 2011 |
Lin S, Yu L, Yang J, Liu Z, Karia B, Bishop AJ, Jackson J, Lozano G, Copland JA, Mu X, Sun B, Sun LZ. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β). The Journal of Biological Chemistry. 286: 44023-34. PMID 22039050 DOI: 10.1074/Jbc.M111.265397 |
0.331 |
|
| 2011 |
Tian M, Ogawa K, Wendt R, Mukhopadhyay U, Balatoni J, Fukumitsu N, Uthamanthil R, Borne A, Brammer D, Jackson J, Mawlawi O, Yang B, Alauddin MM, Gelovani JG. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 934-41. PMID 21571803 DOI: 10.2967/Jnumed.110.086777 |
0.327 |
|
| 2011 |
Wang Y, Suh YA, Fuller MY, Jackson JG, Xiong S, Terzian T, Quintás-Cardama A, Bankson JA, El-Naggar AK, Lozano G. Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation. The Journal of Clinical Investigation. 121: 893-904. PMID 21285512 DOI: 10.1172/Jci44504 |
0.313 |
|
| 2006 |
Jackson JG, Pereira-Smith OM. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Research. 66: 8356-60. PMID 16951143 DOI: 10.1158/0008-5472.Can-06-1752 |
0.303 |
|
| 2006 |
Jackson JG, Pereira-Smith OM. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Molecular and Cellular Biology. 26: 2501-10. PMID 16537896 DOI: 10.1128/Mcb.26.7.2501-2510.2006 |
0.301 |
|
| Show low-probability matches. |